A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus Infection
Conditions: Chronic Hepatitis B Interventions: Drug: ABI-4334; Drug: Placebo Sponsors: Assembly Biosciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population
Conditions: Hepatocellular Carcinoma; Hepatitis B Interventions: Diagnostic Test: Urine test Sponsors: Peking Union Medical College Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
Conditions: Hepatitis B; Hepatitis B Infection Interventions: Device: iStatis HBsAg Test Sponsors: bioLytical Laboratories Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease （OCEAN PROJECT）
Conditions: Nonalcoholic Fatty Liver Disease; Chronic Hepatitis b Interventions: Drug: Peg-Interferon α Sponsors: First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites
Conditions: Hepatitis B; Hepatitis B Infection Interventions: Device: iStatis HBsAg Test Sponsors: bioLytical Laboratories; St Vincent ' s Hospital Melbourne Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Conditions: Chronic Hepatitis B Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo 10mg Tab Sponsors: Chinese University of Hong Kong Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus
Conditions: Hepatitis B; Hepatitis D; Viral Hepatitis Interventions: Diagnostic Test: investigations for Hepatitis D virus Sponsors: National Center for Gastroentestinal and Liver Disease Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
The Treatment of PD-1 Antibody Combined With Peg-IFN α in NAs-suppressed CHB Patients
Conditions: Chronic Hepatitis B Interventions: Drug: Sintilimab; Drug: Peg-IFN α-2b; Drug: NAs Sponsors: Beijing 302 Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.
Conditions: Occult Hepatitis B in Cancer Patients Interventions: Other: Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA Sponsors: Fondazione IRCCS Policlinico San Matteo di Pavia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
Conditions: Chronic Hepatitis b Interventions: Drug: Peginterferon α-2b based treatment group; Drug: NAs monotherapy group Sponsors: Qing XIe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Faculty of Medicine in Assiut and New Valley University to Assess Knowledge, Attitude ,and Practice of Rural Population in a Remote Governorate ( New Valley ) Towards Hepatitis B and C Viruses
Conditions: Hepatitis B; Hepatitis C Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
A Study of LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection
Conditions: Chronic Hepatitis B Interventions: Drug: LW231 tablets; Drug: Placebo Sponsors: Shanghai Longwood Biopharmaceuticals Co., Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Retrospective Observational Study on the Effects of Prebiotics on HBsAg Clearance
Conditions: Chronic Hepatitis B Interventions: Drug: PegIFN α2b; Drug: PegIFNα2b+prebiotics; Drug: Nucleoside analog; Drug: Nucleoside analog+prebiotics Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
Conditions: HBV; Kidney Transplantation; Liver Transplantation Interventions: Drug: Tacrolimus; Drug: Belatacept Sponsors: University Hospital, Grenoble; National Agency for Research on AIDS and Viral Hepatitis (ANRS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
Conditions: Chronic Hepatitis b Interventions: Drug: Terbinafine; Drug: Placebo; Drug: Tenofovir Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
